Causemedix Pharmaceuticals is an early-research biopharma startup, with a specific charter on small molecule drugs.
In particular, our research domain focuses on the cross-talk between the orexinergic and CRF-systems.
Founded by ex-J.P. Morgan, ex-Amgen leaders, our work has the potential to transform the landscape for advancing treatments to difficult-to-target diseases, benefitting patients with unmet needs.
Contact
Please fill out the form below, or email us at
info@causemedix.com
575 Washington Blvd
Jersey City, N.J. 07310